annual EBITDA:
-$66.37M-$14.20M(-27.21%)Summary
- As of today (July 26, 2025), ATYR annual EBITDA is -$66.37 million, with the most recent change of -$14.20 million (-27.21%) on December 31, 2024.
- During the last 3 years, ATYR annual EBITDA has fallen by -$33.66 million (-102.91%).
- ATYR annual EBITDA is now -353.22% below its all-time high of -$14.64 million, reached on December 1, 2020.
Performance
ATYR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$15.39M+$430.00K(+2.72%)Summary
- As of today (July 26, 2025), ATYR quarterly EBITDA is -$15.39 million, with the most recent change of +$430.00 thousand (+2.72%) on March 1, 2025.
- Over the past year, ATYR quarterly EBITDA has increased by +$476.00 thousand (+3.00%).
- ATYR quarterly EBITDA is now -794.18% below its all-time high of $2.22 million, reached on March 1, 2020.
Performance
ATYR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$65.90M+$476.00K(+0.72%)Summary
- As of today (July 26, 2025), ATYR TTM EBITDA is -$65.90 million, with the most recent change of +$476.00 thousand (+0.72%) on March 1, 2025.
- Over the past year, ATYR TTM EBITDA has dropped by -$9.88 million (-17.65%).
- ATYR TTM EBITDA is now -1050.64% below its all-time high of -$5.73 million, reached on March 1, 2014.
Performance
ATYR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ATYR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.2% | +3.0% | -17.6% |
| 3 y3 years | -102.9% | -27.4% | -73.9% |
| 5 y5 years | -207.1% | -794.2% | -354.3% |
ATYR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.9% | at low | -112.2% | +13.3% | -64.3% | +0.7% |
| 5 y | 5-year | -353.2% | at low | -227.9% | +13.3% | -354.3% | +0.7% |
| alltime | all time | -353.2% | at low | -794.2% | +13.3% | -1050.6% | +0.7% |
ATYR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$15.39M(-2.7%) | -$65.90M(-0.7%) |
| Dec 2024 | -$66.37M(+27.2%) | -$15.82M(-10.9%) | -$66.37M(+0.4%) |
| Sep 2024 | - | -$17.75M(+4.9%) | -$66.11M(+10.2%) |
| Jun 2024 | - | -$16.93M(+6.7%) | -$59.97M(+7.1%) |
| Mar 2024 | - | -$15.87M(+2.0%) | -$56.01M(+7.3%) |
| Dec 2023 | -$52.18M(+16.7%) | -$15.55M(+33.8%) | -$52.18M(+18.9%) |
| Sep 2023 | - | -$11.62M(-10.4%) | -$43.88M(-3.2%) |
| Jun 2023 | - | -$12.97M(+7.8%) | -$45.34M(+1.5%) |
| Mar 2023 | - | -$12.03M(+65.9%) | -$44.66M(-0.1%) |
| Dec 2022 | -$44.71M(+36.7%) | - | - |
| Dec 2022 | - | -$7.25M(-44.5%) | -$44.71M(-2.3%) |
| Sep 2022 | - | -$13.08M(+6.3%) | -$45.78M(+14.2%) |
| Jun 2022 | - | -$12.30M(+1.8%) | -$40.10M(+5.8%) |
| Mar 2022 | - | -$12.08M(+45.2%) | -$37.89M(+15.8%) |
| Dec 2021 | -$32.71M(+123.4%) | -$8.32M(+12.4%) | -$32.71M(+12.5%) |
| Sep 2021 | - | -$7.40M(-26.6%) | -$29.09M(+4.3%) |
| Jun 2021 | - | -$10.09M(+46.1%) | -$27.90M(+17.4%) |
| Mar 2021 | - | -$6.91M(+47.1%) | -$23.77M(+62.3%) |
| Dec 2020 | -$14.64M(-32.2%) | -$4.69M(-24.4%) | -$14.64M(-5.9%) |
| Sep 2020 | - | -$6.21M(+4.3%) | -$15.56M(+7.3%) |
| Jun 2020 | - | -$5.96M(-368.7%) | -$14.51M(+4.7%) |
| Mar 2020 | - | $2.22M(-139.5%) | -$13.85M(-35.9%) |
| Dec 2019 | -$21.61M | -$5.61M(+8.8%) | -$21.61M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$5.16M(-2.8%) | -$21.79M(-5.7%) |
| Jun 2019 | - | -$5.30M(-4.3%) | -$23.11M(-16.2%) |
| Mar 2019 | - | -$5.54M(-4.2%) | -$27.58M(-14.0%) |
| Dec 2018 | -$32.07M(-30.9%) | -$5.78M(-10.8%) | -$32.07M(-14.1%) |
| Sep 2018 | - | -$6.49M(-33.6%) | -$37.33M(-10.1%) |
| Jun 2018 | - | -$9.77M(-2.7%) | -$41.52M(-4.5%) |
| Mar 2018 | - | -$10.04M(-9.1%) | -$43.48M(-6.4%) |
| Dec 2017 | -$46.43M(-18.6%) | -$11.04M(+3.4%) | -$46.43M(-2.7%) |
| Sep 2017 | - | -$10.68M(-9.0%) | -$47.70M(-5.9%) |
| Jun 2017 | - | -$11.73M(-9.6%) | -$50.67M(-6.4%) |
| Mar 2017 | - | -$12.98M(+5.5%) | -$54.14M(-5.1%) |
| Dec 2016 | -$57.04M(+22.0%) | -$12.31M(-9.8%) | -$57.04M(-6.5%) |
| Sep 2016 | - | -$13.64M(-10.3%) | -$60.99M(+4.4%) |
| Jun 2016 | - | -$15.21M(-4.2%) | -$58.44M(+8.4%) |
| Mar 2016 | - | -$15.88M(-2.3%) | -$53.92M(+15.3%) |
| Dec 2015 | -$46.75M(+105.7%) | -$16.26M(+46.6%) | -$46.75M(+28.7%) |
| Sep 2015 | - | -$11.09M(+3.8%) | -$36.31M(+16.2%) |
| Jun 2015 | - | -$10.69M(+22.7%) | -$31.24M(+21.5%) |
| Mar 2015 | - | -$8.71M(+49.7%) | -$25.71M(+13.1%) |
| Dec 2014 | -$22.73M(+20.7%) | -$5.82M(-3.3%) | -$22.73M(+34.4%) |
| Sep 2014 | - | -$6.02M(+16.8%) | -$16.90M(+55.3%) |
| Jun 2014 | - | -$5.16M(-10.0%) | -$10.88M(+90.0%) |
| Mar 2014 | - | -$5.73M | -$5.73M |
| Dec 2013 | -$18.83M | - | - |
FAQ
- What is aTyr Pharma, Inc. annual EBITDA?
- What is the all time high annual EBITDA for aTyr Pharma, Inc.?
- What is aTyr Pharma, Inc. annual EBITDA year-on-year change?
- What is aTyr Pharma, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for aTyr Pharma, Inc.?
- What is aTyr Pharma, Inc. quarterly EBITDA year-on-year change?
- What is aTyr Pharma, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for aTyr Pharma, Inc.?
- What is aTyr Pharma, Inc. TTM EBITDA year-on-year change?
What is aTyr Pharma, Inc. annual EBITDA?
The current annual EBITDA of ATYR is -$66.37M
What is the all time high annual EBITDA for aTyr Pharma, Inc.?
aTyr Pharma, Inc. all-time high annual EBITDA is -$14.64M
What is aTyr Pharma, Inc. annual EBITDA year-on-year change?
Over the past year, ATYR annual EBITDA has changed by -$14.20M (-27.21%)
What is aTyr Pharma, Inc. quarterly EBITDA?
The current quarterly EBITDA of ATYR is -$15.39M
What is the all time high quarterly EBITDA for aTyr Pharma, Inc.?
aTyr Pharma, Inc. all-time high quarterly EBITDA is $2.22M
What is aTyr Pharma, Inc. quarterly EBITDA year-on-year change?
Over the past year, ATYR quarterly EBITDA has changed by +$476.00K (+3.00%)
What is aTyr Pharma, Inc. TTM EBITDA?
The current TTM EBITDA of ATYR is -$65.90M
What is the all time high TTM EBITDA for aTyr Pharma, Inc.?
aTyr Pharma, Inc. all-time high TTM EBITDA is -$5.73M
What is aTyr Pharma, Inc. TTM EBITDA year-on-year change?
Over the past year, ATYR TTM EBITDA has changed by -$9.88M (-17.65%)